Therapy Complications
"Adverse Reactions to Iodinated Contrast Media in Patients Treated with Interleukin-2."
Published in Cancer Weekly, December 7th, 1998
According to an abstract submitted by the authors to the 84th Scientific Assembly and Annual Meeting of the Radiological Society of North America, held November 29 - December 4, 1998, in Chicago, Illinois, "Purpose: The purpose of this study is to report the increased incidence of adverse reactions to iodinated contrast media (ICM) in patients treated with systemic interleukin-2 (IL-2). IL-2 is a potent modulator of immune response that has been reported to induce tumor regression in cancer patients and may induce sensitization to radiological contrast media. This phenomenon has been rarely reported in the literature. We present circumstances and management of these reactions...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (1998-12-07)
More Articles from Cancer Weekly
- Suicide Gene Therapy
Tissue-Specific Promoter Targets Cervical Cancer - Cancer Gene Therapy
Antisense Control of Cyclin D1 Reduces Proliferation - Cancer Genetics
Process Identifies a Novel Oncogene - Cancer Immunotherapy
Chemo/Immunotherapy Tolerable in Renal Cancer Patients - Cancer Immunotherapy
Defective Maturation of Hemopoietic Progenitors Creates Complications - Cancer Immunotherapy
Immunological Parameters of TNF(alpha) Immunotherapy Identified - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
